| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027153 |
| Receipt No. | R000031113 |
| Scientific Title | Clinical trial of individual cognitive Behavioral Therapy for chronic pain (single arm trial) |
| Date of disclosure of the study information | 2017/04/26 |
| Last modified on | 2019/05/30 (Ver. 11) |
| Basic information | ||
| Public title | Clinical trial of individual cognitive Behavioral Therapy for chronic pain (single arm trial) | |
| Acronym | Clinical trial of Cognitive Behavioral Therapy for chronic pain | |
| Scientific Title | Clinical trial of individual cognitive Behavioral Therapy for chronic pain (single arm trial) | |
| Scientific Title:Acronym | Clinical trial of Cognitive Behavioral Therapy for chronic pain | |
| Region |
|
|
| Condition | ||
| Condition | Somatic symptom disorder with mainly pain | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Efficacy of Cognitive Behavioral Therapy for chronic pain and consideration of Protocol Contents |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1.Numerical Rating Scale (NRS)
2.Pain Catastrophizing Scale (PCS) (Both are evaluated after 16 weeks.) |
| Key secondary outcomes | After 8 weeks,
1.Numerical Rating Scale (NRS) 2.Pain Catastrophizing Scale (PCS) After 16 weeks, 3.Pain Disability Assessment Scale (PDAS) 4.PHQ-9(Patient Health Questionnare-9) 5.GHQ-7(Generalized anxiety disorder-7) 6.EQ-5D-5L(EuroQol5-Dimension-5Levels) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Cognitive Behavioral Therapy(16 weeks) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients falling under all the following conditions are
targeted. 1) Those who satisfy the diagnostic criteria for somatic symptoms (primary pain) in DSM5 (not excluding depression or other anxiety disorder). 2) Persons who are 18 years of age or older at the time of consent acquisition. 3) After being fully informed of participation of this exam, after fully understanding, it is based on the individual's willingness to do so. Person who obtained document consent form (in case of minors, including parental consent) 4) It can understand cognitive behavioral therapy and has mental and physical condition that can be practiced on a sustainable basis for at least 1 year. |
|||
| Key exclusion criteria | Those who fall under any of the following conditions
are not included. 1) Persons who are expected to have cessation of behavioral cognitive therapy due to complications of severe mental disorders such as organic brain disorder, psychotic disorder, bipolar disorder, drug dependence etc due to these symptoms worsening 2) Persons who have mental developmental delay (refer to JART - 25: Japanese Adult Reading Test25) 3) Those with neurocognitive disorders (dementia) (MMSE: refer to evaluation scores by Mini Mental State examination) 4) those with autistic spectrum spectroscopy (AQ: refer to Autism Spectrum Index) 5) Persons who are expected to have cessation of cognitive behavioral therapy because of the danger of impending suicide. 6) Persons who are anticipated to have cessation of cognitive behavioral therapy because they repeat anti-social behavior. 7) Persons who are predictive of cessation of cognitive behavioral therapy because they have significant progressive physical disorder. 8) Persons who are difficult to contact with researchers. 9) Other persons who are judged inappropriate for the examination responsible doctor or the test sharing psychologist to safely carry out this test. |
|||
| Target sample size | 15 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Chiba University Hospital | ||||||
| Division name | Cognitive Behavior Therapy Center | ||||||
| Zip code | 260-8677 | ||||||
| Address | Inohana1-8-1 Chuo-ku Chiba-shi Chiba prefecture | ||||||
| TEL | 043-226-2027 | ||||||
| k.taguchi@chiba-u.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Chiba University | ||||||
| Division name | Cognitive Behavior Physiology Laboratory | ||||||
| Zip code | 260-8670 | ||||||
| Address | Inohana1-8-1 Chuo-ku Chiba-shi Chiba prefecture | ||||||
| TEL | 043-226-2027 | ||||||
| Homepage URL | |||||||
| k.taguchi@chiba-u.jp | |||||||
| Sponsor | |
| Institute | Chiba University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Academic contribution |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Chiba University Hospital |
| Address | Inohana1-8-1 Chuo-ku Chiba-shi Chiba prefecture |
| Tel | 043-222-7171 |
| chibacrc@mac.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 17 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031113 |